Financhill
Back

Hoth Therapeutics Quote, Financials, Valuation and Earnings

Hoth Therapeutics Price Quote

$0.82
+0.01 (+-3.19%)
(Updated: December 14, 2024 at 5:36 AM ET)

Hoth Therapeutics Key Stats

Sell
39
Hoth Therapeutics (HOTH) is a Sell

Day range:
$0.80 - $0.85
52-week range:
$0.58 - $1.73
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.78%

Volume:
77.9K
Avg. volume:
867.7K
1-year change:
-35.71%
Market cap:
$5.8M
Revenue:
$0
EPS:
$-1.32

How Much Does Hoth Therapeutics Make?

Data Unavailable

Is Hoth Therapeutics Growing As A Company?

Data Unavailable

Hoth Therapeutics Stock Price Performance

  • Did Hoth Therapeutics Stock Go Up Last Month?
    Hoth Therapeutics share price went down by -7.24% last month
  • Did HOTH's Share Price Rise Over The Last Year?
    HOTH share price fell by -35.71% over the past 1 year

What Is Hoth Therapeutics 52-Week High & Low?

Hoth Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Hoth Therapeutics?

  • How Much Debt Does Hoth Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Hoth Therapeutics Have?
    Cash and short term investments quarterly total is $8M
  • What Is Hoth Therapeutics’s Book Value Per Share?
    Book value per share is 1.09

Is Hoth Therapeutics Cash Flow Positive?

  • What Is HOTH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8M
  • What Is Hoth Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3.7M
  • What Is Hoth Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Hoth Therapeutics Return On Invested Capital

Data Unavailable

Hoth Therapeutics Earnings Date & Stock Price

Hoth Therapeutics Competitors

  • Who Are Hoth Therapeutics's Competitors?
    Below is a list of companies who compete with Hoth Therapeutics or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • Inspire Medical Systems Inc (INSP)
    • Myomo Inc (MYO)
    • Xtant Medical Holdings Inc (XTNT)

Hoth Therapeutics Dividend Yield

Hoth Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -3.33%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 4.50
Upside from Last Price: 455.56%

Major Shareholders

  • How many HOTH shares are owned by institutional investors?
    433.6K HOTH shares are owned by institutional investors
  • How many HOTH shares are owned by insiders?
    182.4K HOTH shares are owned by insiders